Encapsulated concentrates processing systems

In interfacial polymerization, monomers react at the interface of two immiscible liquid phases to produce a film that encapsulates the dispersed phase. The process involves an initial emulsification step in which an aqueous phase, containing a reactive monomer and a core material, is dispersed in a nonaqueous continuous phase. This is then followed by the addition of a second monomer to the continuous phase. Monomers in the two phases then diffuse and polymerize at the interface to form a thin film. The degree of polymerization depends on the concentration of monomers, the temperature of the system, and the composition of the liquid phases. 

The term encapsulation has been used to distinguish entrapment preparations in which the biocatalyst environment is comparable to that of the bulk phase and where there is no covalent attachment of the protein to the containment medium (Fig. 6-1 D)[21J. Enzymes or whole cells may be encapsulated within the interior of a microscopic semi-permeable membranes (microencapsulation) or within the interior of macroscopic hollow-fiber membranes. Liposome encapsulation, a common microscopic encapsulation technique, involves the containment of an enzyme within the interior of a spherical surfactant bilayer, usually based on a phospholipid such as lecithin. The dimensions and shape of the liposome are variable and may consist of multiple amphiphile layers. Processes in which microscopic compart-mentalization (cf. living cells) such as multienzyme systems, charge transfer systems, or processes that require a gradient in concentration have employed liposome encapsulation. This method of immobilization is also commonly used for the delivery of therapeutic proteins. 

The versatility of LEMs is clear. From the encapsulation of living cells to the removal of toxic or inhibiting substances, and in their use as a downstream process, liquid emulsion membranes remain a powerful and, as of yet, virtually untapped resource for biochemical engineers. The ability of LEMs to separate and concentrate amino acids demonstrated here gives strength to this observation, and it is anticipated that these systems will enjoy increasing attention in the years to come. 

In this case study, the encapsulation of quercetin in Pluronic F127 from acetone solutions by SAS process is described. Pressure and temperature operating conditions, 10 MPa and 40°C, were chosen in order to operate in the single phase region of the solvent (acetone)-C02 system. Solution flow rate and antisolvent flow rate were 2 mL/min and 2 kg/h. Different solution concentrations and carrier/quercetin ratios were tested in order to optimize the particle production process. 

---